 Jacob Gadwa
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 13 | 2024 | 542 | 2.630 |
Why?
| | Tumor Microenvironment | 9 | 2025 | 631 | 1.000 |
Why?
| | T-Lymphocytes, Regulatory | 5 | 2023 | 373 | 0.840 |
Why?
| | Interleukin-2 | 2 | 2023 | 437 | 0.810 |
Why?
| | Receptor, Anaphylatoxin C5a | 1 | 2021 | 31 | 0.700 |
Why?
| | Complement Inactivating Agents | 1 | 2021 | 46 | 0.690 |
Why?
| | Receptors, Complement | 1 | 2021 | 122 | 0.690 |
Why?
| | Carcinoma, Pancreatic Ductal | 4 | 2025 | 270 | 0.650 |
Why?
| | Ephrin-B2 | 4 | 2024 | 50 | 0.630 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 207 | 0.620 |
Why?
| | Receptor, EphB4 | 3 | 2024 | 36 | 0.590 |
Why?
| | Complement Activation | 1 | 2020 | 381 | 0.550 |
Why?
| | Mycobacterium tuberculosis | 3 | 2025 | 309 | 0.490 |
Why?
| | Pancreatic Neoplasms | 4 | 2025 | 881 | 0.470 |
Why?
| | Immunotherapy | 5 | 2025 | 592 | 0.410 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 3201 | 0.360 |
Why?
| | Tuberculosis | 2 | 2025 | 273 | 0.360 |
Why?
| | Mice | 16 | 2025 | 16915 | 0.340 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 3 | 2023 | 82 | 0.300 |
Why?
| | Papillomavirus Infections | 2 | 2022 | 297 | 0.300 |
Why?
| | Animals | 17 | 2025 | 35307 | 0.280 |
Why?
| | Neoplasms | 1 | 2020 | 2449 | 0.250 |
Why?
| | Toll-Like Receptor 8 | 1 | 2025 | 6 | 0.240 |
Why?
| | Phagosomes | 1 | 2025 | 42 | 0.240 |
Why?
| | Cell Proliferation | 3 | 2021 | 2374 | 0.230 |
Why?
| | PPAR alpha | 1 | 2024 | 58 | 0.220 |
Why?
| | Oleic Acid | 1 | 2024 | 39 | 0.220 |
Why?
| | RNA, Bacterial | 1 | 2025 | 182 | 0.220 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 40 | 0.220 |
Why?
| | Interleukin-7 | 1 | 2024 | 59 | 0.220 |
Why?
| | STAT3 Transcription Factor | 2 | 2022 | 194 | 0.210 |
Why?
| | Tumor Burden | 2 | 2021 | 286 | 0.210 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2024 | 201 | 0.200 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2023 | 169 | 0.200 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 42 | 0.200 |
Why?
| | Cigarette Smoking | 1 | 2023 | 91 | 0.190 |
Why?
| | Radioimmunotherapy | 1 | 2021 | 16 | 0.190 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1247 | 0.180 |
Why?
| | ADAM10 Protein | 1 | 2021 | 30 | 0.180 |
Why?
| | Mycobacteriophages | 1 | 2020 | 2 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 54 | 0.170 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 79 | 0.170 |
Why?
| | Radiation Tolerance | 1 | 2021 | 98 | 0.170 |
Why?
| | Rifampin | 1 | 2020 | 83 | 0.170 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 183 | 0.170 |
Why?
| | Mice, Knockout | 3 | 2021 | 2871 | 0.170 |
Why?
| | Complement C3 | 1 | 2021 | 208 | 0.160 |
Why?
| | Radiation Injuries | 1 | 2021 | 135 | 0.160 |
Why?
| | Humans | 19 | 2025 | 129248 | 0.160 |
Why?
| | Radiosurgery | 1 | 2022 | 320 | 0.160 |
Why?
| | Drug Resistance, Bacterial | 1 | 2020 | 175 | 0.160 |
Why?
| | Microbial Sensitivity Tests | 1 | 2020 | 347 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5439 | 0.160 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 181 | 0.150 |
Why?
| | Antitubercular Agents | 1 | 2020 | 200 | 0.150 |
Why?
| | Dexamethasone | 1 | 2021 | 350 | 0.150 |
Why?
| | Fibrosis | 1 | 2021 | 520 | 0.150 |
Why?
| | Membrane Proteins | 2 | 2021 | 1117 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2024 | 857 | 0.140 |
Why?
| | Dendritic Cells | 1 | 2021 | 479 | 0.140 |
Why?
| | Glioblastoma | 1 | 2020 | 322 | 0.130 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 756 | 0.130 |
Why?
| | Adenocarcinoma | 1 | 2022 | 898 | 0.120 |
Why?
| | Signal Transduction | 3 | 2025 | 4926 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1344 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1173 | 0.110 |
Why?
| | Time Factors | 1 | 2021 | 6543 | 0.080 |
Why?
| | Combined Modality Therapy | 2 | 2022 | 1199 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 942 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2021 | 812 | 0.070 |
Why?
| | Survival Rate | 2 | 2021 | 1869 | 0.060 |
Why?
| | Cell Movement | 2 | 2021 | 944 | 0.060 |
Why?
| | Fenofibrate | 1 | 2024 | 31 | 0.060 |
Why?
| | Prognosis | 2 | 2021 | 3772 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 610 | 0.050 |
Why?
| | Female | 3 | 2025 | 68543 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2022 | 164 | 0.050 |
Why?
| | Apoptosis | 2 | 2021 | 2498 | 0.050 |
Why?
| | STAT1 Transcription Factor | 1 | 2021 | 70 | 0.050 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2021 | 26 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 232 | 0.040 |
Why?
| | Nicotine | 1 | 2023 | 302 | 0.040 |
Why?
| | Fatty Acids | 1 | 2024 | 426 | 0.040 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2021 | 41 | 0.040 |
Why?
| | Lymphocyte Depletion | 1 | 2021 | 131 | 0.040 |
Why?
| | Luciferases | 1 | 2020 | 147 | 0.040 |
Why?
| | Luminescent Measurements | 1 | 2020 | 75 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 381 | 0.040 |
Why?
| | Tuberculosis, Multidrug-Resistant | 1 | 2020 | 57 | 0.040 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2020 | 135 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 483 | 0.040 |
Why?
| | Mice, Nude | 1 | 2020 | 682 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2021 | 427 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2021 | 406 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1056 | 0.040 |
Why?
| | Macrophages | 1 | 2025 | 1484 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2025 | 2276 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1710 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2021 | 803 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2630 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4057 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2021 | 1933 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3074 | 0.020 |
Why?
|
|
Gadwa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|